未登录

A

Andrew E. Greenstein

Gilead Sciences

H指数:19

被引数:1,518

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Glucocorticoid receptor antagonism and beta adrenergic receptor inhibition: Implications in triple-negative breast cancer brain metastasis

ANNALS OF ONCOLOGY

IF65.4

2023-10-010

PRE

The glucocorticoid receptor modulator relacorilant reverses the immunosuppressive effects of cortisol

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2023-07-012

PRE

Genetically engineered human pituitary corticotroph tumor organoids exhibit divergent responses to glucocorticoid receptor modulators

TRANSLATIONAL RESEARCH

IF5.9

2023-06-016

OAAI

Selective glucocorticoid receptor modulation reveals a new role for CLEC10A in patients with solid tumors

CANCER RESEARCH

IF16.6

2023-04-041

PRE

Characterization of Active MMP9 in Chronic Inflammatory Diseases Using a Novel Anti-MMP9 Antibody

IF2.7

2023-01-188

OAAI

Glucocorticoid receptor expression and activity in a phase II ovarian cancer trial of the glucocorticoid receptor modulator relacorilant in combination with nab-paclitaxel

ANNALS OF ONCOLOGY

IF65.4

2022-09-011

OA

Overcoming Taxane Resistance: Preclinical and Phase 1 Studies of Relacorilant, a Selective Glucocorticoid Receptor Modulator, with Nab-Paclitaxel in Solid Tumors

CLINICAL CANCER RESEARCH

IF10.2

2022-05-1816

OAAI

Adrenal tumors provide insight into the role of cortisol in NK cell activity

ENDOCRINE-RELATED CANCER

IF4.6

2021-08-0111

PRE

An integrated framework for quantifying immune-tumour interactions in a 3D co-culture model

COMMUNICATIONS BIOLOGY

IF5.1

2021-06-2413

OAAI

Suppression of tumor immune activity in adrenocortical carcinoma with excess glucocorticoid

CANCER RESEARCH

IF16.6

2020-08-150

PRE

MMP (Matrix Metalloprotease)-9-Producing Monocytes Enable T Cells to Invade the Vessel Wall and Cause Vasculitis

CIRCULATION RESEARCH

IF16.2

2018-08-31118

OAAI

Heterogeneity and mutation in KRAS and associated oncogenes: evaluating the potential for the evolution of resistance to targeting of KRAS G12C

IF7.3

2018-02-1629

OAAI

Inhibition of MMP9 improves anti-tumor immunity by changing the tumor microenvironment to promote T cell trafficking and activation

CANCER RESEARCH

IF16.6

2017-07-011

PRE

Biochemical characterization and structure determination of a potent, selective antibody inhibitor of human MMP9

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2017-04-0181

OAAI

MMP9 Catalytic Activity Is Elevated in Colon Tissue of Patients with IBD

GASTROENTEROLOGY

IF25.1

2016-04-010

PREAI

Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice

IF4.2

2015-12-23190

PREAI

Preexisting drug-resistance mutations reveal unique barriers to resistance for distinct antivirals

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2011-06-0633

OAAI

Novel Mutations in a Tissue Culture-Adapted Hepatitis C Virus Strain Improve Infectious-Virus Stability and Markedly Enhance Infection Kinetics

JOURNAL OF VIROLOGY

IF3.8

2011-04-1531

OAAI

A Major Determinant of Cyclophilin Dependence and Cyclosporine Susceptibility of Hepatitis C Virus Identified by a Genetic Approach

IF4.9

2010-09-2385

OAAI

Novel Hepatitis C Virus Reporter Replicon Cell Lines Enable Efficient Antiviral Screening against Genotype 1a

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2010-08-0151

OAAI